Economic Evaluation of Surgery Alone versus Surgery Plus Adjuvant Therapy for Glioblastomas in India

This is the authors' abstract. We don't add key points for this paper.

Surgery without adjuvant therapy is currently the only cost-effective treatment strategy for GBMs in India. In order to provide a cost-effective Stupp protocol, health policymakers should address the high costs of adjuvant RT, invest in methods for screening and early diagnosis to improve PFS, and develop policies to improve disease-related QOL and productivity.